Multifractal analysis of tumour microscopic images in the prediction of breast cancer chemotherapy response

Verfasser / Beitragende:
[Jelena Vasiljevic, Jelena Pribic, Ksenija Kanjer, Wojtek Jonakowski, Jelena Sopta, Dragica Nikolic-Vukosavljevic, Marko Radulovic]
Ort, Verlag, Jahr:
2015
Enthalten in:
Biomedical Microdevices, 17/5(2015-10-01), 1-5
Format:
Artikel (online)
ID: 605480117
LEADER caa a22 4500
001 605480117
003 CHVBK
005 20210128100413.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s10544-015-9995-0  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10544-015-9995-0 
245 0 0 |a Multifractal analysis of tumour microscopic images in the prediction of breast cancer chemotherapy response  |h [Elektronische Daten]  |c [Jelena Vasiljevic, Jelena Pribic, Ksenija Kanjer, Wojtek Jonakowski, Jelena Sopta, Dragica Nikolic-Vukosavljevic, Marko Radulovic] 
520 3 |a Due to the individual heterogeneity, highly accurate predictors of chemotherapy response in invasive breast cancer are needed for effective chemotherapeutic management. However, predictive molecular determinants for conventional chemotherapy are only emerging and still incorporate a high degree of predictive variability. Based on such pressing need for predictive performance improvement, we explored the value of pre-therapy tumour histology image analysis to predict chemotherapy response. Fractal analysis was applied to hematoxylin/eosin stained archival tissue of diagnostic biopsies derived from 106 patients diagnosed with invasive breast cancer. The tissue was obtained prior to neoadjuvant anthracycline-based chemotherapy and patients were subsequently divided into three groups according to their actual chemotherapy response: partial pathological response (pPR), pathological complete response (pCR) and progressive/stable disease (PD/SD). It was shown that multifractal analysis of breast tumour tissue prior to chemotherapy indeed has the capacity to distinguish between histological images of the different chemotherapy responder groups with accuracies of 91.4% for pPR, 82.9% for pCR and 82.1% for PD/SD. F(α)max was identified as the most important predictive parameter. It represents the maximum of multifractal spectrum f(α), where α is the Hölder's exponent. This is the first study investigating the predictive value of multifractal analysis as a simple and cost-effective tool to predict the chemotherapy response. Improvements in chemotherapy prediction provide clinical benefit by enabling more optimal chemotherapy decisions, thus directly affecting the quality of life and survival. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Anthracycline  |2 nationallicence 
690 7 |a Breast cancer  |2 nationallicence 
690 7 |a Chemotherapy  |2 nationallicence 
690 7 |a Drug response  |2 nationallicence 
690 7 |a Fractal  |2 nationallicence 
690 7 |a Histology  |2 nationallicence 
690 7 |a Multifractal  |2 nationallicence 
690 7 |a Prediction  |2 nationallicence 
700 1 |a Vasiljevic  |D Jelena  |u Institute "Mihajlo Pupin”, Volgina 15, Belgrade, Serbia  |4 aut 
700 1 |a Pribic  |D Jelena  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
700 1 |a Kanjer  |D Ksenija  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
700 1 |a Jonakowski  |D Wojtek  |u Institute "Mihajlo Pupin”, Volgina 15, Belgrade, Serbia  |4 aut 
700 1 |a Sopta  |D Jelena  |u Medical Faculty, Institute of Pathology, University of Belgrade, Dr Subotica 1, Belgrade, Serbia  |4 aut 
700 1 |a Nikolic-Vukosavljevic  |D Dragica  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
700 1 |a Radulovic  |D Marko  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
773 0 |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/5(2015-10-01), 1-5  |x 1387-2176  |q 17:5<1  |1 2015  |2 17  |o 10544 
856 4 0 |u https://doi.org/10.1007/s10544-015-9995-0  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10544-015-9995-0  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Vasiljevic  |D Jelena  |u Institute "Mihajlo Pupin”, Volgina 15, Belgrade, Serbia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Pribic  |D Jelena  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kanjer  |D Ksenija  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Jonakowski  |D Wojtek  |u Institute "Mihajlo Pupin”, Volgina 15, Belgrade, Serbia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sopta  |D Jelena  |u Medical Faculty, Institute of Pathology, University of Belgrade, Dr Subotica 1, Belgrade, Serbia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nikolic-Vukosavljevic  |D Dragica  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Radulovic  |D Marko  |u Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/5(2015-10-01), 1-5  |x 1387-2176  |q 17:5<1  |1 2015  |2 17  |o 10544